Continuous Positive Airway Pressure (CPAP) Service

Obstructive Sleep Apnoea (OSA) is a prevalent sleep-related respiratory disorder characterised by recurrent upper airway obstruction during sleep, resulting in intermittent pauses in breathing. This leads to fragmented sleep, excessive daytime sleepiness, and significantly increases the risk of developing serious comorbidities such as hypertension, diabetes, cardiovascular disease, and stroke.

OSA affects approximately 5% of the population, with a substantial proportion remaining undiagnosed. The condition is particularly burdensome in individuals with coexisting chronic obstructive pulmonary disease (COPD) or obesity hypoventilation syndrome (OSAHS), where symptoms and health risks are further exacerbated.

Continuous Positive Airway Pressure (CPAP) therapy is the first-line treatment for OSA, delivering a constant flow of air via a mask to maintain airway patency during sleep. Effective management requires consistent nightly use.

CPAP devices typically have a lifespan of 7 years, while masks are single-patient use items requiring replacement every 6 to 12 months and regular patient cleaning to ensure optimal function and hygiene. At Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT), there are currently around 5,500 patients utilising CPAP therapy and a further 300 patients using other forms of non-invasive ventilation.

This generates an annual requirement for approximately 6,000 masks and tubes, and 1,200 filters. The service manages roughly 950 patient contacts per month, with half pertaining to the resupply of consumables.

Diagnostic capacity was increased by 25% in 2024, resulting in a rise in therapy initiations and overall service demand. The objective of this procurement is to enhance patient access to CPAP consumables and support services, reduce administrative and storage burdens, and achieve cost efficiencies.

Streamlining the supply chain and support processes will release clinical resources, improve patient experience, and reduce unplanned hospital or primary care attendances. Proactive follow-up and device recovery initiatives will support therapy adherence and ensure optimal use of resources, thereby facilitating high-quality, efficient, and patient-centred care. The core components of the required service include: - Procurement of CPAP devices and consumables - Mask management and replacement - Provision of a patient support line - Access to a patient and clinician portal - Consignment stock supply for timely distribution